This generation of C-Class doubles down on what makes Mercedes, Mercedes: luxury, refinement, and tech. As a miniature S-Class, it’s an appealing prospect, though not without compromises. Design is ...
Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus erythematosus (SLE) have been revealed, and have not disappointed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback